Date published: 2025-9-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cefpodoxime Proxetil (CAS 87239-81-4)

0.0(0)
Write a reviewAsk a question

Application:
Cefpodoxime Proxetil is a broad spectrum antibacterial
CAS Number:
87239-81-4
Purity:
≥97%
Molecular Weight:
557.60
Molecular Formula:
C21H27N5O9S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Cefotiam Hexetil Hydrochloride, cataloged under CAS number 95789-30-3, is the hydrochloride salt form of cefotiam hexetil, a prodrug of cefotiam, which is a second-generation cephalosporin. This compound has been extensively used in non-clinical research to explore bacterial resistance mechanisms and the pharmacodynamics of prodrugs. The active form, cefotiam, functions by targeting and inhibiting penicillin-binding proteins (PBPs) which are essential for bacterial cell wall synthesis. These PBPs are involved in the cross-linking process of peptidoglycan chains that provide structural integrity to the bacterial cell wall. By binding to these proteins, cefotiam disrupts the normal synthesis and assembly of the cell wall, leading to bacterial cell lysis and death. Cefotiam Hexetil Hydrochloride is particularly useful in research for studying the conversion efficiency of prodrugs into their active forms within various environments, which is critical for understanding the pharmacokinetics of cephalosporins. Moreover, its use in studies helps in examining how structural modifications affect the stability and activity of cephalosporins against beta-lactamase producing bacteria, providing valuable insights into the design and development of more effective antibacterial agents capable of circumventing bacterial resistance.


Cefpodoxime Proxetil (CAS 87239-81-4) References

  1. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.  |  Utsui, Y., et al. 1987. Antimicrob Agents Chemother. 31: 1085-92. PMID: 3310868
  2. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.  |  Yurtdaş-Kırımlıoğlu, G. 2021. Drug Dev Ind Pharm. 47: 1261-1278. PMID: 34606394
  3. Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data.  |  Azuma, T., et al. 2022. Antibiotics (Basel). 11: PMID: 35453223
  4. Studies on orally active cephalosporin esters.  |  Fujimoto, K., et al. 1987. J Antibiot (Tokyo). 40: 370-84. PMID: 3570989
  5. Cephalosporin as Potent Urease and Tyrosinase Inhibitor: Exploration through Enzyme Inhibition, Kinetic Mechanism, and Molecular Docking Studies.  |  Alqahtani, YS., et al. 2022. Biomed Res Int. 2022: 1092761. PMID: 35937399
  6. Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs.  |  Gao, YY., et al. 2022. Front Vet Sci. 9: 1048823. PMID: 36311679
  7. Evaluation of new formulations for neutralizing antimicrobial preservatives in pharmaceutical preparations.  |  Katerji, A., et al. 2023. Heliyon. 9: e14555. PMID: 36967902
  8. Pharmacokinetic assessment of cefpodoxime proxetil in diabetic rats.  |  Mittal, G., et al. 2023. J Diabetes Metab Disord. 22: 385-392. PMID: 37255782
  9. Ecological spectroscopic methodologies for quantifying co-administered drugs in human plasma by photochemical quantum mechanical simulation.  |  S Eissa, M., et al. 2024. Heliyon. 10: e24466. PMID: 38317894
  10. HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.  |  Patil, PS., et al. 2024. J Taibah Univ Med Sci. 19: 252-262. PMID: 38616800

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Cefpodoxime Proxetil, 10 mg

sc-211044
10 mg
$140.00